4.7 Article

Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)

Journal

JOURNAL OF PERSONALIZED MEDICINE
Volume 11, Issue 6, Pages -

Publisher

MDPI
DOI: 10.3390/jpm11060511

Keywords

breast cancer; screening; risk prediction; risk stratification

Funding

  1. Genome Canada
  2. Canadian Institutes for Health Research
  3. Genome Quebec
  4. Quebec Ministry of Economic, Science and Innovation
  5. CHU de Quebec Foundation
  6. CHU de Quebec-Universite Laval Research Center
  7. Ontario Research Fund
  8. Quebec Breast Cancer Foundation

Ask authors/readers for more resources

Early detection of breast cancer through screening reduces mortality, but potential harms must be considered. Personalized risk assessment may improve screening programs, and the PERSPECTIVE I&I project aims to identify novel genes, enhance risk prediction tools, develop a socio-ethical framework, and conduct economic analysis for risk-based screening implementation. The goal is to empower women with informed decisions about screening and prevention.
Early detection of breast cancer through screening reduces breast cancer mortality. The benefits of screening must also be considered within the context of potential harms (e.g., false positives, overdiagnosis). Furthermore, while breast cancer risk is highly variable within the population, most screening programs use age to determine eligibility. A risk-based approach is expected to improve the benefit-harm ratio of breast cancer screening programs. The PERSPECTIVE I&I (Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation) project seeks to improve personalized risk assessment to allow for a cost-effective, population-based approach to risk-based screening and determine best practices for implementation in Canada. This commentary describes the four inter-related activities that comprise the PERSPECTIVE I&I project. 1: Identification and validation of novel moderate to high-risk susceptibility genes. 2: Improvement, validation, and adaptation of a risk prediction web-tool for the Canadian context. 3: Development and piloting of a socio-ethical framework to support implementation of risk-based breast cancer screening. 4: Economic analysis to optimize the implementation of risk-based screening. Risk-based screening and prevention is expected to benefit all women, empowering them to work with their healthcare provider to make informed decisions about screening and prevention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available